Doxy-PEP could select for ceftriaxone resistance in Neisseria gonorrhoeae - Authors' reply
- PMID: 40280142
- DOI: 10.1016/S1473-3099(25)00235-X
Doxy-PEP could select for ceftriaxone resistance in Neisseria gonorrhoeae - Authors' reply
Conflict of interest statement
AFL reports research grants paid to her institution from Gilead, GSK, Merck, the US National Institutes of Health, and ViiV Healthcare; laboratory kits and supplies from Cepheid and Hologic; and receipt of the study drug from Mayne Pharma. DD reports receiving laboratory kits and supplies from Cepheid and Hologic, and receipt of the study drug from Mayne Pharma. CC received honoraria from Gilead and Merck as a scientific advisor (unrelated to this research); research grants from the US National Institutes of Health and the Gates Foundation; laboratory kits and supplies from Cepheid and Hologic; and the study drug from Mayne Pharma.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous